Recent Updates
Recently added Catalysts
PLSM Positive Sentiment

Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States

Key Takeaway: Pulsenmore Ltd. has partnered with Ouma Health to integrate its FDA-authorized home ultrasound technology into Ouma's virtual maternity care model. This collaboration aims to enhance access to remote prenatal care across the United States, creating a scalable solution for the adoption of home ultrasound in prenatal care. The partnership signifies a step forward in improving maternal health services.
Price reaction · baseline $3.41 (2026-06-23 close) · hit pre-market · 1 other PLSM headline(s) in the window, move may be shared
day 0 close
+93.3%
day 1
+73%
day 3
+86.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Partnership aims to enhance access to prenatal care.
  • Integration of FDA-authorized technology is a significant advancement.
  • Scalable pathway for home ultrasound adoption is promising.

Full Press Release Details

FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal care across the United States
RAMAT GAN, Israel,June 24, 2026/PRNewswire/ --Pulsenmore Ltd.(NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health, a leading provider of virtual maternity care solutions in the United States.

Frequently Asked Questions

What technology is Pulsenmore integrating with Ouma Health?

Pulsenmore is integrating its FDA-authorized home ultrasound technology.

What is the goal of the partnership between Pulsenmore and Ouma Health?

The partnership aims to expand access to remote prenatal care across the U.S.

How does the partnership benefit prenatal care?

It creates a scalable pathway for adopting home ultrasound in prenatal care.

Last updated: Jun 24, 2026